EUVIMEDEUVIMED entdecken
Crossref

Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS G12D Inhibitor, in Colorectal Cancer Treatment

Masahiro Kataoka, Masato Kitazawa, Satoshi Nakamura, Makoto Koyama, Yuta Yamamoto, Satoru Miyazaki, Nao Hondo, Hirokazu Tanaka, Yuji Soejima

Anticancer Research · 2023-10 · 43 (10) · 4341-4348

DOI: 10.21873/anticanres.16629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.09.2023. Verfasst von Masahiro Kataoka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School o…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Colorectal Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsColorectal NeoplasmsHumansCetuximabProto-Oncogene Proteins p21(ras)Caco-2 CellsErbB ReceptorsMutationHeterocyclic Compounds, 2-RingNaphthalenes

Stichwörter der Autor:innen

Colorectal cancerEGFRG12DKRASMRTX1133

Substanzen

CetuximabProto-Oncogene Proteins p21(ras)Antineoplastic AgentsErbB ReceptorsKRASG12D inhibitor MRTX1133Heterocyclic Compounds, 2-RingNaphthalenesKRAS protein, human

Autor:innen und Institutionen

  • Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
  • Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan kita118@shinshu-u.ac.jp.

Zitieren

APA

Kataoka, M., Kitazawa, M., Nakamura, S., Koyama, M., Yamamoto, Y., Miyazaki, S., Hondo, N., Tanaka, H., & Soejima, Y. (2023). Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS G12D Inhibitor, in Colorectal Cancer Treatment. Anticancer Research, 43(10), 4341-4348. https://doi.org/10.21873/anticanres.16629

Vancouver

Kataoka M, Kitazawa M, Nakamura S, Koyama M, Yamamoto Y, Miyazaki S, et al. Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS G12D Inhibitor, in Colorectal Cancer Treatment. Anticancer Research. 2023;43(10):4341-4348. doi:10.21873/anticanres.16629

BibTeX
@article{Kataoka2023,
  author = {Kataoka, Masahiro and Kitazawa, Masato and Nakamura, Satoshi and Koyama, Makoto and Yamamoto, Yuta and Miyazaki, Satoru and Hondo, Nao and Tanaka, Hirokazu and Soejima, Yuji},
  title = {Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS G12D Inhibitor, in Colorectal Cancer Treatment},
  journal = {Anticancer Research},
  year = {2023},
  volume = {43},
  number = {10},
  pages = {4341--4348},
  doi = {10.21873/anticanres.16629}
}
Kostenlos starten →